Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 3, 385-90

Safety and Efficacy of Pegylated Liposomal Doxorubicin in HIV-associated Kaposi's Sarcoma

Affiliations

Safety and Efficacy of Pegylated Liposomal Doxorubicin in HIV-associated Kaposi's Sarcoma

Francesca Cainelli et al. Biologics.

Abstract

Kaposi's sarcoma is a vascular tumor linked to the presence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) and the incidence of which has increased considerably the world over after the onset of the human immunodeficiency virus (HIV) pandemic. Antiretroviral therapy combined with cytotoxic agents has been established as the treatment of choice in the past 10 years. Among chemotherapeutic agents, pegylated liposomal doxorubicin has become the preferred one for patients with HIV-associated Kaposi's sarcoma in Western countries. The drug in this formulation localizes better to the tumor and has higher efficacy. Skin toxicity, mucositis, and leukopenia/neutropenia are the main side effects. Hepatotoxicity and mild cardiotoxicity are observed less frequently. Pegylated liposomal doxorubicin impacts favorably on quality of life. Although cost effective in Western countries, the drug is less so in developing countries.

Keywords: HIV infection; Kaposi’s sarcoma; pegylated liposomal doxorubicin.

Similar articles

See all similar articles

Cited by 2 articles

References

    1. Engels EA, Biggar RJ, Marshall VA, et al. Detection and quantitation of Kaposi’s sarcoma associated herpes virus to predict AIDS associated Kaposi’s sarcoma. AIDS. 2003;17:1847–1851. - PubMed
    1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–1869. - PubMed
    1. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi’s sarcoma. J Virol. 1996;70:549–558. - PMC - PubMed
    1. Cesarman E, Chang Y, Moore PS, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186–1191. - PubMed
    1. Soulier J, Grollet L, Oskenhendler E, et al. Kaposi’s sarcoma–associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood. 1995;86:1276–1280. - PubMed
Feedback